Hao Peng

1.4k total citations · 1 hit paper
25 papers, 939 citations indexed

About

Hao Peng is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Hao Peng has authored 25 papers receiving a total of 939 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 9 papers in Cancer Research and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Hao Peng's work include RNA modifications and cancer (11 papers), Cancer-related molecular mechanisms research (8 papers) and Cancer-related gene regulation (6 papers). Hao Peng is often cited by papers focused on RNA modifications and cancer (11 papers), Cancer-related molecular mechanisms research (8 papers) and Cancer-related gene regulation (6 papers). Hao Peng collaborates with scholars based in China, Australia and United States. Hao Peng's co-authors include Xiaobin Cui, Yunzhao Chen, Jianming Hu, Lan Yang, Hong Zhou, Dandan Wang, Ying Huang, Binbin Chen, Jun Li and Lirong Liang and has published in prestigious journals such as Nature Communications, Oncogene and Emerging infectious diseases.

In The Last Decade

Hao Peng

25 papers receiving 934 citations

Hit Papers

Epigenetically upregulated oncoprotein PLCE1 drives esoph... 2019 2026 2021 2023 2019 100 200 300

Peers

Hao Peng
Xuan Yang China
Hao Zheng China
Long Wu China
Xuan Yang China
Hao Peng
Citations per year, relative to Hao Peng Hao Peng (= 1×) peers Xuan Yang

Countries citing papers authored by Hao Peng

Since Specialization
Citations

This map shows the geographic impact of Hao Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hao Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hao Peng more than expected).

Fields of papers citing papers by Hao Peng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hao Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hao Peng. The network helps show where Hao Peng may publish in the future.

Co-authorship network of co-authors of Hao Peng

This figure shows the co-authorship network connecting the top 25 collaborators of Hao Peng. A scholar is included among the top collaborators of Hao Peng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hao Peng. Hao Peng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Yilin, Yu‐Hong Huang, Wei Li, et al.. (2025). Intratumoral microbiota-aided fusion radiomics model for predicting tumor response to neoadjuvant chemoimmunotherapy in triple-negative breast cancer. Journal of Translational Medicine. 23(1). 352–352. 3 indexed citations
2.
Peng, Hao, et al.. (2024). Neeko: Leveraging Dynamic LoRA for Efficient Multi-Character Role-Playing Agent. 12540–12557. 1 indexed citations
3.
Chen, Binbin, Li Li, Ying Huang, et al.. (2024). N6-methyladenosine in 28S rRNA promotes oncogenic mRNA translation and tyrosine catabolism. Cell Reports. 44(1). 115139–115139. 2 indexed citations
4.
Peng, Hao, Min He, Jinxia Li, et al.. (2023). SLC43A2 and NFκB signaling pathway regulate methionine/cystine restriction-induced ferroptosis in esophageal squamous cell carcinoma via a feedback loop. Cell Death and Disease. 14(6). 347–347. 22 indexed citations
5.
Wang, Yubing, Yufei Feng, Hao Peng, et al.. (2023). Bioinformatics-Based Identification of CircRNA-MicroRNA-mRNA Network for Calcific Aortic Valve Disease. Genetics Research. 2023. 1–12. 1 indexed citations
6.
Chen, Binbin, Ying Huang, Shuiqing He, et al.. (2023). N6-methyladenosine modification in 18S rRNA promotes tumorigenesis and chemoresistance via HSF4b/HSP90B1/mutant p53 axis. Cell chemical biology. 30(2). 144–158.e10. 24 indexed citations
7.
Han, Hui, Chunlong Yang, Jieyi Ma, et al.. (2022). N7-methylguanosine tRNA modification promotes esophageal squamous cell carcinoma tumorigenesis via the RPTOR/ULK1/autophagy axis. Nature Communications. 13(1). 1478–1478. 125 indexed citations
8.
Peng, Hao, Binbin Chen, Wei Wei, et al.. (2022). N6-methyladenosine (m6A) in 18S rRNA promotes fatty acid metabolism and oncogenic transformation. Nature Metabolism. 4(8). 1041–1054. 95 indexed citations
9.
Chen, Binbin, Wei Jiang, Ying Huang, et al.. (2022). N7-methylguanosine tRNA modification promotes tumorigenesis and chemoresistance through WNT/β-catenin pathway in nasopharyngeal carcinoma. Oncogene. 41(15). 2239–2253. 91 indexed citations
10.
Xu, Zheyuan, Ran Wang, Xu Li, et al.. (2021). RHBDD1 silencing inhibited cell growth and invasion of non-small cell lung cancer by mediating ZEB1/PI3K/AKT signaling pathway. Journal of Molecular Histology. 52(3). 503–510. 9 indexed citations
11.
12.
Peng, Hao, Binbin Chen, Xiaohui Wang, Yunxian Mo, & Fei Han. (2021). Prognostic Value of Regression Rate of Plasma EBV DNA After Induction Chemotherapy for Stage II-IVA Nasopharyngeal Carcinoma. Frontiers in Oncology. 11. 689593–689593. 2 indexed citations
13.
Ma, Li, Leyong Yuan, Xiaojun Yang, et al.. (2021). RCN1 induces sorafenib resistance and malignancy in hepatocellular carcinoma by activating c-MYC signaling via the IRE1α–XBP1s pathway. Cell Death Discovery. 7(1). 298–298. 28 indexed citations
14.
Chen, Yunzhao, Dandan Wang, Hao Peng, et al.. (2019). Epigenetically upregulated oncoprotein PLCE1 drives esophageal carcinoma angiogenesis and proliferation via activating the PI-PLCε-NF-κB signaling pathway and VEGF-C/ Bcl-2 expression. Molecular Cancer. 18(1). 1–1. 306 indexed citations breakdown →
15.
Chen, Fangfang, et al.. (2019). Integrative genomics analysis of hub genes and their relationship with prognosis and signaling pathways in esophageal squamous cell carcinoma. Molecular Medicine Reports. 20(4). 3649–3660. 27 indexed citations
16.
Peng, Hao, Huawei Yang, Liwei Song, et al.. (2016). Sustained delivery of siRNA/PEI complex from in situ forming hydrogels potently inhibits the proliferation of gastric cancer. Journal of Experimental & Clinical Cancer Research. 35(1). 57–57. 29 indexed citations
17.
Yang, Lan, Ling Chen, Tingting Li, et al.. (2015). Heterozygote of TAP1 Codon637 decreases susceptibility to HPV infection but increases susceptibility to esophageal cancer among the Kazakh populations. Journal of Experimental & Clinical Cancer Research. 34(1). 70–70. 19 indexed citations
18.
Cui, Xiaobin, Xuelian Pang, Li Su, et al.. (2014). A case of blastic plasmacytoid dendritic cell neoplasm with ecchymotic lesions on the whole body.. PubMed. 7(7). 4391–9. 9 indexed citations
19.
Cui, Xiaobin, Li Su, Xuelian Pang, et al.. (2014). Significance of elevated ERK expression and its positive correlation with EGFR in Kazakh patients with esophageal squamous cell carcinoma.. PubMed. 7(5). 2382–91. 14 indexed citations
20.
Wang, Yue, Hao Peng, Bo Lu, et al.. (2010). Causes of Infection after Earthquake, China, 2008. Emerging infectious diseases. 16(6). 974–975. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026